Search research articles
Contact Us
Filters
Showing results (71-80 of 1,584) with videos related to
Page
of 159
Sort By:
Journal of Medicinal Chemistry
|
May 15, 2009
Doubly loaded cycloSaligenyl-pronucleotides - 5,5'-Bis-(cycloSaligenyl-2',3'-dideoxy-2',3'-didehydrothymidine monophosphates)
Nicolas Gisch, Jan Balzarini, Chris Meier
Journal of Medicinal Chemistry
|
October 7, 2008
Studies on enzyme-cleavable dialkoxymethyl-cyclosaligenyl-2',3'-dideoxy-2',3'-didehydrothymidine monophosphates
Nicolas Gisch, Jan Balzarini, Chris Meier
Tropical Medicine and Infectious Disease
|
July 2, 2021
Public Perceptions on Non-Pharmaceutical Interventions for West Nile Virus Infections: A Survey from an Endemic Area in Northern Italy
Matteo Riccò, Simona Peruzzi, Federica Balzarini
The Journal of Biological Chemistry
|
April 15, 1989
Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds
J Balzarini, P Herdewijn, E De Clercq
Medicinal Research Reviews
|
July 14, 2006
The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention
Miguel Stevens, Erik De Clercq, Jan Balzarini
Antiviral Chemistry & Chemotherapy
|
January 15, 2011
Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: bisphenylboronic acids
Paul C Trippier, Jan Balzarini, Christopher McGuigan
Biochemical Pharmacology
|
July 21, 1999
Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation
S Hatse, E De Clercq, J Balzarini
Molecular Pharmacology
|
November 1, 1996
Evidence for distinction of the differentiation-inducing activities and cytostatic properties of 9-(2-phosphonylmethoxyethyl)adenine and a variety of differentiation-inducing agents in human erythroleukemia K562 cells
S Hatse, E De Clercq, J Balzarini
Molecular Pharmacology
|
October 1, 1993
Human immunodeficiency virus type 1 drug-resistance patterns with different 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives
J Balzarini, A Karlsson, E De Clercq
Acta Tropica
|
September 24, 2004
African Burkitt lymphoma successfully treated with CEOP polychemotherapy
Enrico Rino Bregani, Laura Balzarini, Mara Cabibbe
Page
of 159
Search research articles
Search
Showing results (71-80 of 1,584) with videos related to
Sort By:
Page
of 159
Journal of Medicinal Chemistry
|
May 15, 2009
Doubly loaded cycloSaligenyl-pronucleotides - 5,5'-Bis-(cycloSaligenyl-2',3'-dideoxy-2',3'-didehydrothymidine monophosphates)
Nicolas Gisch, Jan Balzarini, Chris Meier
Journal of Medicinal Chemistry
|
October 7, 2008
Studies on enzyme-cleavable dialkoxymethyl-cyclosaligenyl-2',3'-dideoxy-2',3'-didehydrothymidine monophosphates
Nicolas Gisch, Jan Balzarini, Chris Meier
Tropical Medicine and Infectious Disease
|
July 2, 2021
Public Perceptions on Non-Pharmaceutical Interventions for West Nile Virus Infections: A Survey from an Endemic Area in Northern Italy
Matteo Riccò, Simona Peruzzi, Federica Balzarini
The Journal of Biological Chemistry
|
April 15, 1989
Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds
J Balzarini, P Herdewijn, E De Clercq
Medicinal Research Reviews
|
July 14, 2006
The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention
Miguel Stevens, Erik De Clercq, Jan Balzarini
Antiviral Chemistry & Chemotherapy
|
January 15, 2011
Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: bisphenylboronic acids
Paul C Trippier, Jan Balzarini, Christopher McGuigan
Biochemical Pharmacology
|
July 21, 1999
Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation
S Hatse, E De Clercq, J Balzarini
Molecular Pharmacology
|
November 1, 1996
Evidence for distinction of the differentiation-inducing activities and cytostatic properties of 9-(2-phosphonylmethoxyethyl)adenine and a variety of differentiation-inducing agents in human erythroleukemia K562 cells
S Hatse, E De Clercq, J Balzarini
Molecular Pharmacology
|
October 1, 1993
Human immunodeficiency virus type 1 drug-resistance patterns with different 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives
J Balzarini, A Karlsson, E De Clercq
Acta Tropica
|
September 24, 2004
African Burkitt lymphoma successfully treated with CEOP polychemotherapy
Enrico Rino Bregani, Laura Balzarini, Mara Cabibbe
Page
of 159